Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Strobl-Kacerovsky, S; Greil, R; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Solkner, L; Fesl, C; Gnant, M; Fitzal, F.

Breast Cancer Res Treat (2024). https://doi.org/10.1007/s10549-023-07186-6.

https://link.springer.com/content/pdf/10.1007/s10549-023-07186-6.pdf